[email protected] Our Pipeline
  • Instagram
  • Twitter
Hoth Therapeutics, Inc.
  • Instagram
  • Twitter
  • Home
  • About
    • About Hoth
    • Letter from our CEO
    • Our Team
    • Scientific Advisory Board
    • Careers
  • For Patients
    • For Patients
    • Expanded Access Program
    • Clinical Trials
    • Oncology
    • Neurology
    • Inflammatory
    • Dermatology
    • Devices
    • Pipeline
  • Partnering
    • University Collaborations
    • Partnering With Hoth
  • Investors/Media
  • Contact
Select Page

Investor Relations

Enhancing shareholder value through exceptional business performance and practices, and through responsible and effective communication with its shareholders.

Investor relations
  • Overview
  • News/Events
    • News Releases
    • Media Coverage
    • Events and Webcasts
  • stock Information
    • stock overview
    • interactive chart
    • Analyst Coverage
  • Latest Presentation
  • Corporate Governance
  • Board of Directors
  • SEC filings
  • Resources
    • Investor Alerts
    • FAQs
    • information request
  • Pipeline

Financial Calculators

Helpful Links

  • Home
  • Investors
  • About us
  • Board of Directors
  • Our Team
  • Contact us

Contact
(646) 756-2997
[email protected]

About
Hoth Therapeutics

At Hoth Therapeutics, we strive to develop innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life. We are a catalyst in early-stage pharmaceutical research and development, elevating promising drugs from the bench to pre-clinical and clinical testing.

Contact
(646) 756-2997
[email protected]

Follow Us


  • Twitter

  • Instagram
© 2023 Hoth Therapeutics. All Rights Reserved
Terms & ConditionsPrivacy PolicySite Map

You can see how this popup was set up in our step-by-step guide: https://wppopupmaker.com/guides/auto-opening-announcement-popups/

Disclaimer

You are about to review presentations, reports and/or filings of Hoth Therapeutics, Inc., that contain time-sensitive information. The information contained therein is only accurate as of the date thereof. Hoth Therapeutics, Inc. will not be reviewing or updating the material that is contained in these items after the date thereof. The information contained therein may be updated, amended, supplemented or otherwise altered by subsequent presentations, reports and/or filings by Hoth Therapeutics, Inc.

I Accept I Decline

Corporate Governance

Reports Regarding LMP Automotive Holdings’ Accounting or Auditing Matters or Other Concerns and Communications with the Board of Directors.

Shareholders and interested parties may communicate directly with the Board of Directors, the Audit Committee of the Board of Directors with respect to accounting issues, questionable accounting or auditing matters or internal accounting controls, any other Board committee, any individual Director, any group of Directors or the Lead Independent Director by e-mailing [email protected].

Reports may be made anonymously or confidentially.